AC
STJ

Ascend Capital’s St Jude Medical STJ Stock Holding History

Ascend Capital’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-364,560
Closed -$22.5M – 172
2015
Q4 		$22.5M Buy
+364,560
New +$23M 0.79% 41

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Ascend Capital's STJ Position: Q1 2016 in Review

Ascend Capital sold out of St Jude Medical (STJ) in Q1 2016, closing a stake of 364,560 shares — an estimated $22.5M sold.

Ascend Capital first reported a position in STJ in Q4 2015 and held it in 1 quarter. The position peaked at $22.5M in Q4 2015. 570 funds tracked by Wall St. Rank hold STJ as of Q1 2016.

  • Ascend Capital reported no remaining St Jude Medical position as of Q1 2016 after selling out during the quarter.
  • Ascend Capital sold 364,560 St Jude Medical shares in Q1 2016, an estimated $22.5M.
  • Ascend Capital first reported a position in St Jude Medical in Q4 2015 and held it in 1 quarter.
  • Ascend Capital's St Jude Medical position peaked at $22.5M in Q4 2015.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2016.

Based on Ascend Capital's 13F filing for Q1 2016, filed 13 May 2016.